Evidence map›Paper›PMID 24911320›Full record

ArticleBehavioral neuroscience2014

Dopamine modulates novelty seeking behavior during decision making.

Vincent D Costa, Valery L Tran, Janita Turchi, Bruno B Averbeck

Open access · greenAbstract read
In one paragraph

Article in Behavioral neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 264 citations in OpenAlex.

  1. Disentangling the roles of dopamine and noradrenaline in the exploration-exploitation tradeoff during human decision-making.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Dynamic changes of dopamine neuron activity and plasticity at different stages of negative reinforcement learning.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Associations BetweenBiomedicines · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vincent D CostaLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health.
Valery L TranLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health.
Janita TurchiLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health.
Bruno B AverbeckLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health.
National Institutes of Health · US

Funding

Frontal Striatal Systems and Dopamine in Normal and Pathological BehaviorZIAMH002928 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI AVERBECK, BRUNO · 2010 to 2025
$29.0M
Pharmacology Of Stimulus Memory And Habit FormationZIAMH002039 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MISHKIN, MORTIMER · 2009 to 2017
$10.0M
Intramural NIH HHS ZIA MH002928
6 · The paper itself

Abstract

Novelty seeking refers to the tendency of humans and animals to explore novel and unfamiliar stimuli and environments. The idea that dopamine modulates novelty seeking is supported by evidence that novel stimuli excite dopamine neurons and activate brain regions receiving dopaminergic input. In addition, dopamine is shown to drive exploratory behavior in novel environments. It is not clear whether dopamine promotes novelty seeking when it is framed as the decision to explore novel options versus the exploitation of familiar options. To test this hypothesis, we administered systemic injections of saline or GBR-12909, a selective dopamine transporter (DAT) inhibitor, to monkeys and assessed their novelty seeking behavior during a probabilistic decision making task. The task involved pseudorandom introductions of novel choice options. This allowed monkeys the opportunity to explore novel options or to exploit familiar options that they had already sampled. We found that DAT blockade increased the monkeys' preference for novel options. A reinforcement learning (RL) model fit to the monkeys' choice data showed that increased novelty seeking after DAT blockade was driven by an increase in the initial value the monkeys assigned to novel options. However, blocking DAT did not modulate the rate at which the monkeys learned which cues were most predictive of reward or their tendency to exploit that knowledge. These data demonstrate that dopamine enhances novelty-driven value and imply that excessive novelty seeking-characteristic of impulsivity and behavioral addictions-might be caused by increases in dopamine, stemming from less reuptake.

Indexed as

AnimalsChoice BehaviorDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsExploratory BehaviorMacaca mulattaMaleModels, PsychologicalNeuropsychological TestsPiperazinesProbabilityReinforcement, PsychologyDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsPiperazinesvanoxerine

Identifiers

PMID24911320
PMCPMC5861725
OpenAlexW2133403871

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.